miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-200b-3p | ||||
miRNA Stemloop AC | MI0000342 | ||||
miRNA Stemloop ID | hsa-mir-200b | ||||
Sequence | uaauacugccugguaaugauga | ||||
TTD Target(s) Regulated by This miRNA | Vascular endothelial growth factor receptor 2 (KDR) | Successful Target | Target Info | [1] | |
Apoptosis regulator Bcl-2 (BCL-2) | Successful Target | Target Info | [2] | ||
Programmed cell death 1 ligand 1 (PD-L1) | Successful Target | Target Info | [3] | ||
Vascular endothelial growth factor A (VEGFA) | Successful Target | Target Info | [1] | ||
Vascular endothelial growth factor receptor 1 (FLT-1) | Successful Target | Target Info | [1] | ||
Inhibitor of nuclear factor kappa-B kinase beta (IKKB) | Clinical trial Target | Target Info | [4] | ||
DNA [cytosine-5]-methyltransferase 1 (DNMT1) | Clinical trial Target | Target Info | [5] | ||
DNA [cytosine-5]-methyltransferase 3B (DNMT3B) | Clinical trial Target | Target Info | [6] | ||
Enhancer of zeste homolog 2 (EZH2) | Successful Target | Target Info | [5] | ||
Fibronectin (FN1) | Clinical trial Target | Target Info | [7] | ||
Rho-associated protein kinase 2 (ROCK2) | Successful Target | Target Info | [8] | ||
Rotamase Pin1 (PIN1) | Clinical trial Target | Target Info | [9] | ||
X-linked inhibitor of apoptosis protein (XIAP) | Clinical trial Target | Target Info | [2] | ||
Notch-1 receptor (NOTCH1) | Clinical trial Target | Target Info | [10] | ||
Fascin (FSCN1) | Clinical trial Target | Target Info | [11] | ||
Transcription factor Sp1 (SP1) | Clinical trial Target | Target Info | [6] | ||
DNA [cytosine-5]-methyltransferase 3A (DNMT3A) | Patented-recorded Target | Target Info | [6] | ||
Extracellular signal-regulated kinase 5 (ERK5) | Patented-recorded Target | Target Info | [12] | ||
Transcription factor AP-1 (JUN) | Discontinued Target | Target Info | [13] | ||
Transforming protein RhoA (RHOA) | Discontinued Target | Target Info | [14] | ||
Lactate dehydrogenase A (LDHA) | Literature-reported Target | Target Info | [15] | ||
Cyclic AMP-responsive element-binding protein (CREB1) | Literature-reported Target | Target Info | [16] | ||
GATA-binding factor 4 (GATA4) | Literature-reported Target | Target Info | [17] | ||
Lysyl oxidase (LOX) | Literature-reported Target | Target Info | [18] | ||
Polycomb complex protein BMI-1 (BMI1) | Clinical trial Target | Target Info | [19] | ||
Protein C-ets-1 (ETS1) | Literature-reported Target | Target Info | [20] | ||
CDK inhibitor 1B p27Kip1 (CDKN1B) | Literature-reported Target | Target Info | [21] | ||
Zinc finger E-box-binding homeobox 2 (ZEB2) | Literature-reported Target | Target Info | [22] | ||
G1/S-specific cyclin-E2 (CCNE2) | Literature-reported Target | Target Info | [23] | ||
Protein(s) Regulated by This miRNA | Arginine-glutamic acid dipeptide repeats protein | Regulated Protein | [24] | ||
Crk-like protein | Regulated Protein | [25] | |||
Disintegrin and metalloproteinase domain-containing protein 12 | Regulated Protein | [26] | |||
E3 ubiquitin-protein ligase RING2 | Regulated Protein | [27] | |||
Engulfment and cell motility protein 2 | Regulated Protein | [28] | |||
Erbin | Regulated Protein | [28] | |||
ETS translocation variant 5 | Regulated Protein | [29] | |||
Fermitin family homolog 2 | Regulated Protein | [30] | |||
Forkhead box protein G1 | Regulated Protein | [31] | |||
Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial | Regulated Protein | [32] | |||
Hereditary hemochromatosis protein | Regulated Protein | [33] | |||
Heterogeneous nuclear ribonucleoprotein A3 | Regulated Protein | [33] | |||
Homeobox protein Hox-B5 | Regulated Protein | [28] | |||
Kelch-like protein 20 | Regulated Protein | [28] | |||
Krueppel-like factor 11 | Regulated Protein | [28] | |||
Matrin-3 | Regulated Protein | [34] | |||
Moesin | Regulated Protein | [35] | |||
Mothers against decapentaplegic homolog 2 | Regulated Protein | [36] | |||
Oxidation resistance protein 1 | Regulated Protein | [37] | |||
PH domain leucine-rich repeat-containing protein phosphatase 1 | Regulated Protein | [38] | |||
Polycomb protein SUZ12 | Regulated Protein | [39] | |||
Probable ATP-dependent RNA helicase DDX53 | Regulated Protein | [40] | |||
Probetacellulin | Regulated Protein | [41] | |||
Protein transport protein Sec23A | Regulated Protein | [38] | |||
Protein VAC14 homolog | Regulated Protein | [28] | |||
Proto-oncogene Wnt-1 | Regulated Protein | [42] | |||
Ras and Rab interactor 2 | Regulated Protein | [28] | |||
Ras association domain-containing protein 2 | Regulated Protein | [28] | |||
Ras-related protein Rab-18 | Regulated Protein | [43] | |||
Ras-related protein Rab-21 | Regulated Protein | [44] | |||
Ras-related protein Rab-23 | Regulated Protein | [43] | |||
Ras-related protein Rab-3B | Regulated Protein | [44] | |||
Receptor-type tyrosine-protein phosphatase delta | Regulated Protein | [28] | |||
Rho GTPase-activating protein 7 | Regulated Protein | [33] | |||
Rho-related GTP-binding protein RhoE | Regulated Protein | [45] | |||
Septin-7 | Regulated Protein | [28] | |||
SHC-transforming protein 1 | Regulated Protein | [28] | |||
Transcription factor 7-like 1 | Regulated Protein | [28] | |||
Tyrosine-protein phosphatase non-receptor type 12 | Regulated Protein | [46] | |||
Ubiquitin carboxyl-terminal hydrolase BAP1 | Regulated Protein | [28] | |||
Ubiquitin-like protein ATG12 | Regulated Protein | [47] | |||
WD repeat-containing protein 37 | Regulated Protein | [28] | |||
Wiskott-Aldrich syndrome protein family member 3 | Regulated Protein | [48] | |||
Zinc finger E-box-binding homeobox 1 | Regulated Protein | [49] | |||
Zinc finger protein ZFPM2 | Regulated Protein | [28] | |||
References | |||||
REF 1 | Regulation of vascular endothelial growth factor signaling by miR-200b. Mol Cells. 2011 Jul;32(1):77-82. | ||||
REF 2 | miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol. 2012 Mar;69(3):723-31. | ||||
REF 3 | Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells. PLoS One. 2017 Jan 5;12(1):e0168822. | ||||
REF 4 | A negative feedback loop between miR-200b and the nuclear factor-B pathway via IKBKB/IKK- in breast cancer cells. FEBS J. 2016 Jun;283(12):2259-71. | ||||
REF 5 | DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. Cancer Lett. 2015 Apr 10;359(2):198-205. | ||||
REF 6 | miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res. 2013 Oct 15;19(20):5602-12. | ||||
REF 7 | MiRNA-200b represses transforming growth factor-1-induced EMT and fibronectin expression in kidney proximal tubular cells. Am J Physiol Renal Physiol. 2013 May 15;304(10):F1266-73. | ||||
REF 8 | Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. Br J Cancer. 2013 Dec 10;109(12):3092-104. | ||||
REF 9 | Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis. J Biol Chem. 2013 Nov 8;288(45):32742-52. | ||||
REF 10 | Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Carcinogenesis. 2013 Jul;34(7):1601-10. | ||||
REF 11 | miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1. Mol Med Rep. 2016 Aug;14(2):1835-40. | ||||
REF 12 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.Genes Dev. 2011 Oct 15;25(20):2173-86. | ||||
REF 13 | Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. Genome Biol. 2014 Jan 7;15(1):R9. | ||||
REF 14 | MiRNA-200b Regulates RMP7-Induced Increases in Blood-Tumor Barrier Permeability by Targeting RhoA and ROCKII. Front Mol Neurosci. 2016 Feb 5;9:9. | ||||
REF 15 | miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma. Oncotarget. 2016 Jul 26;7(30):48423-48431. | ||||
REF 16 | MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma. Mol Cell Biochem. 2013 Jul;379(1-2):51-8. | ||||
REF 17 | miR-200b targets GATA-4 during cell growth and differentiation. RNA Biol. 2013 Apr;10(4):465-80. | ||||
REF 18 | RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2. Oncogene. 2014 Jul 3;33(27):3528-37. | ||||
REF 19 | Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008 Nov 15;68(22):9125-30. | ||||
REF 20 | miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem. 2011 Jan 21;286(3):2047-56. | ||||
REF 21 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010 Apr 2;141(1):129-41. | ||||
REF 22 | The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008 May;10(5):593-601. | ||||
REF 23 | MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2. Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):523-31. | ||||
REF 24 | The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila.Cell. 2007 Oct 5;131(1):136-45. | ||||
REF 25 | CRKL oncogene is downregulated by p53 through miR-200s.Cancer Sci. 2015 Aug;106(8):1033-40. | ||||
REF 26 | ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.BMC Cancer. 2015 Mar 4;15:93. | ||||
REF 27 | Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell. 2011 Aug 16;20(2):187-99. | ||||
REF 28 | Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.Cell. 2009 Dec 11;139(6):1096-108. | ||||
REF 29 | MicroRNA-200b Impacts Breast Cancer Cell Migration and Invasion by Regulating Ezrin-Radixin-Moesin.Med Sci Monit. 2016 Jun 8;22:1946-52. | ||||
REF 30 | miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2.Carcinogenesis. 2014 Feb;35(2):292-301. | ||||
REF 31 | MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.Biomed Pharmacother. 2016 Apr;79:294-301. | ||||
REF 32 | Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1372-82. | ||||
REF 33 | The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells.Int J Oncol. 2013 Aug;43(2):548-60. | ||||
REF 34 | MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis.Clin Endocrinol (Oxf). 2010 Jun;72(6):744-51. | ||||
REF 35 | MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.Oncogene. 2014 Jul 31;33(31):4077-88. | ||||
REF 36 | miR-200b inhibits TGF-1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.Cell Death Dis. 2013 Mar 14;4:e541. | ||||
REF 37 | MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model.Invest Ophthalmol Vis Sci. 2013 Mar 5;54(3):1689-97. | ||||
REF 38 | Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.Mol Cancer Res. 2014 Feb;12(2):250-63. | ||||
REF 39 | SUZ12 depletion suppresses the proliferation of gastric cancer cells.Cell Physiol Biochem. 2013;31(6):778-84. | ||||
REF 40 | miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.J Biol Chem. 2013 Dec 20;288(51):36502-18. | ||||
REF 41 | ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J Clin Invest. 2014 Jun;124(6):2696-708. | ||||
REF 42 | Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22.Cancer Lett. 2013 Oct 28;340(1):72-81. | ||||
REF 43 | miR-200b as a prognostic factor targets multiple members of RAB family in glioma.Med Oncol. 2014 Mar;31(3):859. | ||||
REF 44 | miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.J Transl Med. 2014 Jan 21;12:17. | ||||
REF 45 | MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells.Mol Cell Biochem. 2010 Nov;344(1-2):261-6. | ||||
REF 46 | Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006 Jun;130(7):2113-29. | ||||
REF 47 | MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma.Oncotarget. 2015 Oct 20;6(32):32805-20. | ||||
REF 48 | The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion.J Biol Chem. 2009 Nov 27;284(48):33019-29. | ||||
REF 49 | The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008 May 30;283(22):14910-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.